Eskag Pharma Expands WHO-GMP Certified Facility in India

KOLKATTA, India - May 6, 2025 - PRLog -- Haridwar, India – April 6, 2025 – Eskag Pharma Pvt. Ltd., a leading third-party and contract pharmaceutical manufacturer in India, proudly announces the expansion of its WHO-GMP certified manufacturing facility located in SIDCUL, Haridwar. This strategic move underscores Eskag Pharma's commitment to quality, scalability, and international healthcare standards.

The upgraded facility enhances the company's production capacity across multiple dosage forms including tablets, capsules, syrups, suspensions, creams, ointments, and injectables. With over 46 years of pharmaceutical expertise, Eskag Pharma continues to be a trusted partner for pharmaceutical companies across Africa, LATAM, MENA, and the CIS countries.

"Our mission is to deliver world-class pharmaceutical solutions at cost-effective rates. This expansion strengthens our ability to meet growing international demand while ensuring compliance with stringent global standards," said [Insert Name], Managing Director of Eskag Pharma.

In addition to production enhancement, the facility complies with WHO-GMP, ISO 9001:2008, and HACCP standards. The company also provides dossier support including CTD, ACTD, and CoPP documentation, facilitating quick product registrations across regulated and semi-regulated markets.

Eskag Pharma specializes in third-party manufacturing, custom branding, and multilingual packaging — offering end-to-end solutions tailored for overseas partners. With a robust presence in therapeutic areas such as gynecology, gastroenterology, nephrology, and dermatology, the company is well-positioned to serve the evolving healthcare needs globally.

Backed by successful partnerships with reputed pharma brands like Strides, Savavet, Bliss GVS, and Caplin Point, Eskag Pharma continues to grow as a reliable contract manufacturer in India.